Gilani Fahad Syed, Farooqui Sarah, Doddamani Rajiv, Gruberg Luis
Division of Cardiovascular Medicine, Boston University School of Medicine, Boston Medical Center. Boston, MA, USA.
Division of Cardiovascular Disease, Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, USA.
Clin Med Insights Cardiol. 2015 May 28;9(Suppl 2):23-8. doi: 10.4137/CMC.S19707. eCollection 2015.
Cardiogenic shock (CS) is a life-threatening condition associated with significant morbidity and mortality. Pharmacological therapy is often the first line of treatment but mechanical support can provide substantial hemodynamic improvement in refractory CS. Percutaneous mechanical support devices are placed in a minimally invasive manner and provide life-saving assistance to the failing myocardium. We review the percutaneous devices currently available, the evidence behind their use, and the new advances in percutaneous technology being evaluated for the treatment of CS.
心源性休克(CS)是一种危及生命的疾病,伴有显著的发病率和死亡率。药物治疗通常是一线治疗方法,但机械支持可为难治性CS提供显著的血流动力学改善。经皮机械支持装置以微创方式置入,为衰竭的心肌提供挽救生命的辅助。我们回顾了目前可用的经皮装置、其使用背后的证据以及正在评估用于治疗CS的经皮技术的新进展。